NGM Biopharmaceuticals’ $100 Million Common Stock Offering

Cooley LLP advised NGM Biopharmaceuticals, while Davis Polk & Wardwell advised Jefferies, as sales agent in the offering.NGM Biopharmaceuticals (NASDAQ:NGM) announced its common stock for up to an…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now